跳至主要内容
临床试验/NCT04904887
NCT04904887Unknown不适用

Clinical Outcomes With a New Monofocal Intraocular Lens Enhanced for Intermediate Vision

Dar Al Shifa Hospital2 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2020年11月1日最近更新:
适应症

试验速览

阶段
不适用
入组人数
40
试验地点
2
主要终点
intermediate vision assessment

研究概览

简要总结

phacoemulsification with insertion of EYHANCE IOL to improve near and intermediate vision

详细描述

insertion of new intraocular lens enhanced for intermediate vision

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
40 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • normal ocular examination apart from cataract.

排除标准

  • previous ocular surgery.
  • ocular pathology or corneal abnormalities.
  • endothelial cell count below 2000 cells/mm
  • corneal astigmatism greater than 1.0 diopter (D) measured with Scheimpflug tomography (Sirius, CSO, Italy).

结局指标

主要结局

intermediate vision assessment

时间窗: 6 months postoperatively

Standardized logarithm of the minimum angle of resolution (logMAR) charts were used for visual acuity measurement at 80 cm .

near vision assessment

时间窗: 6 months postoperatively

Standardized logarithm of the minimum angle of resolution (logMAR) charts were used for visual acuity measurement at 40 cm.

次要结局

  • defocus curve(6 months postoperatively)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

magda torky

catract and refractive surgery specialist

Dar Al Shifa Hospital

研究点 (2)

Loading locations...

相似试验